Efficacy of Oxymetholone in Severe and Nonsevere Acquired Aplastic Anemia: A Propensity Score Matching Analysis
Worachaya Pengthina,1 Pirun Saelue2 1Pharmaceutical Care Training Center, Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 2Clinical Hematology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhl...
Main Authors: | Pengthina W, Saelue P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Journal of Blood Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-of-oxymetholone-in-severe-and-nonsevere-acquired-aplastic-ane-peer-reviewed-fulltext-article-JBM |
Similar Items
-
Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
by: Yufei Zhao, et al.
Published: (2023-01-01) -
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia
by: Yihong Guan, et al.
Published: (2022-02-01) -
The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes
by: Momen Nassani, et al.
Published: (2023-05-01) -
70-Day Supraphysiologic Dose of the Power-Enhancing Drug Oxymetholone: the Effects on Oogenesis in NMRI Mice
by: M. Azarniya, et al.
Published: (2007-04-01) -
Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities
by: Timothy S. Olson, et al.
Published: (2022-11-01)